Sri Lanka MRP Approval and Price Control

1. Key takeaways

Sri Lanka applies price control to registered products: registered products must complete Maximum Retail Price (MRP) approval and registration, pricing references the International Reference Pricing (IRP) and must comply with the government’s affordability policy; NMRA publishes the dollar exchange rate used for price processing monthly (336.05 rupees in October 2026). Because of exchange-rate movement, NMRA publishes the dollar rate for price processing each month and announces, in batches, the lists of MRP adjustments approved on account of currency depreciation. Price control therefore runs as a continuing monthly cycle alongside registration, not as a one-time approval at the end of the process.

• Registered products require MRP approval and registration; a registration certificate alone does not permit pricing and sale.
• Pricing references the International Reference Pricing (IRP) and the government’s affordability policy.
• NMRA publishes the dollar exchange rate used for price processing every month.
• The published rate for October 2026 was 336.05 rupees.
• MRP revision applications on account of currency depreciation are approved by the pricing division and announced in batches.
• After MRP approval, a valid import licence must be submitted promptly to the Licensing Division.

2. Legal basis

The pricing framework is administered within NMRA by the dedicated pricing bodies, and its main elements are published on the NMRA website and official announcements. The table below lists the elements in the order of the source.

Two administrative features stand out in this framework. First, the monthly rate publication gives every price-related calculation a defined reference point, so price submission materials can state exactly which month’s rate they used. Second, the batch announcement of depreciation-driven MRP adjustments means revisions are processed in groups rather than continuously, and tracking those announcements is part of the compliance routine. The October 2026 rate of 336.05 rupees illustrates the practical effect: the same dollar reference price produces a different rupee figure from month to month, so the date of the rate used in any submission is as material as the price itself, and both should appear on the face of the document.

3. Expert insights

Insight one: price control and registration are two parallel lines, not one. Obtaining the registration certificate does not mean the product can be priced and sold — MRP approval is an independent stage. Companies that plan their market entry as a single registration timeline routinely discover this late: the certificate arrives, the launch is scheduled, and only then does the pricing workstream begin, compressing it against the launch date. Building the MRP stage into the project plan from the outset costs nothing and removes that compression entirely.

Insight two: the monthly exchange-rate announcement ties price to rate. NMRA publishes the dollar rate used for price processing each month, and companies must prepare their price submission materials on the rate of the current month. This follows the same monthly-update logic as fee conversion, so an organisation that has already built its fee budgeting around month-stamped rates can extend the same discipline to pricing with no new machinery: the rate source differs, but the habit of citing month and figure is identical.

Insight three: MRP approval must connect onward to the import licence. The official announcement explicitly requires that after approval, a valid import licence be submitted promptly to the Licensing Division; otherwise subsequent processing is delayed. The approval is therefore not the end of the chain but a link in it, and the handover from the pricing workstream to the licensing workstream should be a named step with a named owner, not an assumption that someone will remember. Taken together, the three insights describe a pricing workstream that lives on a calendar: rates published monthly, submissions tied to the current rate, approvals announced in batches, and licences handed over on approval. A client who runs this loop monthly finds price control manageable; a client who treats it as an event finds it recurring at inconvenient moments.

4. Practical recommendations

• GRZAN recommends that clients put the three items — exchange rate, price, import licence — into the same monthly rhythm: at the start of each month, check the dollar rate published by NMRA → prepare or adjust the MRP submission accordingly → after approval, submit a valid import licence immediately.
• These three steps form a closed loop and avoid stalls caused by rate changes or document handover gaps.
• Check the published rate at the start of every month and record it, so each price submission can cite the rate it used.
• Prepare MRP submissions against the IRP and the affordability policy, documenting the reference basis for each product.
• Track the batch announcements of MRP revision approvals, so a depreciation-driven adjustment is picked up in the cycle it appears.
• Treat submission of the valid import licence to the Licensing Division as a dated task in the month the MRP is approved, not a later follow-up.

5. Verification checklist

• □ The dollar rate published by NMRA for the current month has been checked
• □ The MRP submission has been prepared against the IRP and the affordability policy
• □ The publication of MRP revision approval lists is being tracked
• □ A valid import licence has been submitted promptly after approval
• □ The price and exchange-rate rhythm has been incorporated into the monthly compliance calendar

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support across South Asia, including Sri Lanka. Our team prepares dossiers to NMRA expectations, manages submissions and deficiency responses, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com

Regulatory information verified as of 28 October 2026.